Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology
钇-90标记的伊布妥单抗联合高剂量卡巴萘韦、依托泊苷、阿糖胞苷和美法仑治疗非霍奇金淋巴瘤的II期研究：组织学的作用
期刊:Biology of Blood and Marrow Transplantation
影响因子:
doi:10.1016/j.bbmt.2017.03.004
Krishnan, Amrita Y; Palmer, Joycelynne; Nademanee, Auayporn P; Chen, Robert; Popplewell, Leslie L; Tsai, Ni-Chun; Sanchez, James F; Simpson, Jennifer; Spielberger, Ricardo; Yamauchi, Dave; Forman, Stephen J
